Pacific Smiles Group (ASX:PSQ) has reported a promising start to the 2024-25 financial year, with patient fees rising by 10.9% to $50.8 million in the first two months. This positive momentum reflects the company’s efforts to enhance the utilization of its existing dental centers, a key focus area under the leadership of CEO Andrew Vidler.
For the full year ending June 30, Pacific Smiles posted a significant increase in profit after tax, reaching $8 million, up from $2.4 million in the previous year. This growth is underpinned by an 8.7% rise in group revenue, which totaled $179.8 million. The company’s strong financial performance highlights its resilience and ability to drive growth in a competitive market.
Despite these gains, a $327 million buyout proposal from private equity firm Crescent Capital was rejected by shareholders at a meeting on August 8. The offer, priced at $2.05 per share, was notably opposed by co-founder Dr. Alex Abrahams, among others, signaling confidence in the company's future prospects.
In addition to its solid financial results, Pacific Smiles increased its final dividend payout to 3.25 cents per share, up from 2.27 cents per share a year earlier. This move further underscores the company's commitment to delivering value to its shareholders as it continues to expand and optimize its operations across Australia.